Literature DB >> 5647240

Treatment of 126 cases of advanced ovarian carcinoma with cyclophosphamide.

R E Beck, D A Boyes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5647240      PMCID： PMC1923922     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  12 in total

Review 1.  Chemotherapy in the management of ovarian carcinoma: a review.

Authors:  J S Malpas
Journal:  J R Soc Med       Date:  1979-05       Impact factor: 5.344

Review 2.  Update in cancer chemotherapy: genitourinary tract cancer, Part 5: Ovarian cancer.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1988-05       Impact factor: 1.798

3.  Sclerosing alveolitis induced by cyclophosphamide. Ultrastructural observations on alveolar injury and repair.

Authors:  V E Gould; J Miller
Journal:  Am J Pathol       Date:  1975-12       Impact factor: 4.307

Review 4.  Comparative activity of ifosfamide and cyclophosphamide.

Authors:  W Brade; S Seeber; K Herdrich
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

5.  Prospective study with HEXA-CAF combination in ovarian carcinoma.

Authors:  G De Palo; R Demicheli; P Valagussa; M De Lena; E Villa
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

6.  Combination v. sequential therapy with melphalan, 5-fluorouracil and methotrexate for advanced ovarian cancer.

Authors:  A B Miller; D J Klaassen; D A Boyes; D J Dodds; A Gerulath; M E Kirk; M Levitt; J G Pearson; C Wall
Journal:  Can Med Assoc J       Date:  1980-09-06       Impact factor: 8.262

7.  A case of interstitial pneumonia associated with systemic sclerosis and primary peritoneal serous carcinoma successfully treated with cyclophosphamide.

Authors:  Shunichi Kawamura; Toshio Kubo; Kenji Takada; Ryota Sunami; Sachi Okawa; Yoshitaka Iwamoto; Atsuko Hirabae; Akihiko Taniguchi; Yoshinobu Maeda; Katsuyuki Kiura; Masahiro Tabata
Journal:  Int Cancer Conf J       Date:  2021-03-16

8.  Metronomic oral cyclophosphamide (MOC) in the salvage therapy of heavily treated recurrent ovarian cancer patients: a retrospective, multicenter study.

Authors:  Gabriella Ferrandina; Giacomo Corrado; Floriana Mascilini; Paola Malaguti; Riccardo Samaritani; Mariagrazia Distefano; Valeria Masciullo; Alessia Di Legge; Antonella Savarese; Giovanni Scambia
Journal:  BMC Cancer       Date:  2014-12-13       Impact factor: 4.430

Review 9.  Achievements of cancer chemotherapy.

Authors:  J S Tobias; J M Whitehouse
Journal:  J R Coll Physicians Lond       Date:  1976-10

10.  Oral metronomic chemotherapy for recurrent & refractory epithelial ovarian cancer: A retrospective analysis.

Authors:  Aparna Sharma; Prabhat Singh Malik; Sachin Khurana; Sunesh Kumar; Neerja Bhatla; M D Ray; Lalit Kumar
Journal:  Indian J Med Res       Date:  2019-12       Impact factor: 2.375
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.